Effects of vasoactive drugs on oxygen consumption in endotoxin shock.
D000818:Animals; D001794:Blood Pressure; D001810:Blood Volume / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003911:Dextrans / Q000627:therapeutic use; D004285:Dogs; D004926:Escherichia coli; D006400:Hematocrit; D006863:Hydrogen-Ion Concentration; D007545:Isoproterenol / Q000627:therapeutic use*; D007773:Lactates / Q000097:blood; D009638:Norepinephrine / Q000627:therapeutic use*; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects*; D010643:Phenoxybenzamine / Q000627:therapeutic use*; D011773:Pyruvates / Q000097:blood; D012772:Shock, Septic / Q000188:drug therapy* / Q000503:physiopathology; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D003911:Dextrans; D007773:Lactates; D011773:Pyruvates; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D007545:Isoproterenol; D010100:Oxygen; D009638:Norepinephrine